Literature DB >> 21907176

Integrin αv expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer.

Christel van den Hoogen1, Geertje van der Horst, Henry Cheung, Jeroen T Buijs, Rob C M Pelger, Gabri van der Pluijm.   

Abstract

Integrins participate in multiple cellular processes, including cell adhesion, migration, proliferation, survival, and the activation of growth factor receptors. Recent studies have shown that expression of αv integrins is elevated in the prostate cancer stem/progenitor cell subpopulation compared with more differentiated, committed precursors. Here, we examine the functional role of αv integrin receptor expression in the acquisition of a metastatic stem/progenitor phenotype in human prostate cancer. Stable knockdown of αv integrins expression in PC-3M-Pro4 prostate cancer cells coincided with a significant decrease of prostate cancer stem/progenitor cell characteristics (α2 integrin, CD44, and ALDH(hi)) and decreased expression of invasion-associated genes Snail, Snail2, and Twist. Consistent with these observations, αv-knockdown strongly inhibited the clonogenic and migratory potentials of human prostate cancer cells in vitro and significantly decreased tumorigenicity and metastatic ability in preclinical models of orthotopic growth and bone metastasis. Our data indicate that integrin αv expression is functionally involved in the maintenance of a highly migratory, mesenchymal cellular phenotype as well as the acquisition of a stem/progenitor phenotype in human prostate cancer cells with metastasis-initiating capacity.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21907176      PMCID: PMC3204028          DOI: 10.1016/j.ajpath.2011.07.011

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  53 in total

Review 1.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

2.  Prospective identification of tumorigenic prostate cancer stem cells.

Authors:  Anne T Collins; Paul A Berry; Catherine Hyde; Michael J Stower; Norman J Maitland
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

Review 3.  The tumour microenvironment as a target for chemoprevention.

Authors:  Adriana Albini; Michael B Sporn
Journal:  Nat Rev Cancer       Date:  2007-02       Impact factor: 60.716

Review 4.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

5.  Evaluation of the frequency of putative prostate cancer stem cells in primary and metastatic prostate cancer.

Authors:  Colby L Eaton; Marc Colombel; Gabri van der Pluijm; Marco Cecchini; Antoinette Wetterwald; Jenny Lippitt; Ishtiaq Rehman; Freddie Hamdy; George Thalman
Journal:  Prostate       Date:  2010-06-01       Impact factor: 4.104

Review 6.  Alpha-v integrins as therapeutic targets in oncology.

Authors:  Jeffrey A Nemeth; Marian T Nakada; M Trikha; Zhihui Lang; Michael S Gordon; Gordon C Jayson; Robert Corringham; Uma Prabhakar; Hugh M Davis; Robert A Beckman
Journal:  Cancer Invest       Date:  2007-10       Impact factor: 2.176

7.  In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue.

Authors:  Natalia Guzmán-Ramírez; Maureen Völler; Antoinette Wetterwald; Markus Germann; Neil A Cross; Cyrill A Rentsch; Jack Schalken; George N Thalmann; Marco G Cecchini
Journal:  Prostate       Date:  2009-11-01       Impact factor: 4.104

8.  Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression.

Authors:  A T Collins; F K Habib; N J Maitland; D E Neal
Journal:  J Cell Sci       Date:  2001-11       Impact factor: 5.285

9.  ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.

Authors:  Ting Li; Yun Su; Yuping Mei; Qixin Leng; Bingjie Leng; Zhenqiu Liu; Sanford A Stass; Feng Jiang
Journal:  Lab Invest       Date:  2009-12-14       Impact factor: 5.662

10.  Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.

Authors:  Bhavik Desai; Michael J Rogers; Meenakshi A Chellaiah
Journal:  Mol Cancer       Date:  2007-03-07       Impact factor: 27.401

View more
  36 in total

Review 1.  Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Aspects Med       Date:  2013-08-29

Review 2.  Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?

Authors:  Nayoung Lee; Steven R Barthel; Tobias Schatton
Journal:  Lab Invest       Date:  2013-10-14       Impact factor: 5.662

3.  High αv Integrin Level of Cancer Cells Is Associated with Development of Brain Metastasis in Athymic Rats.

Authors:  Yingjen Jeffrey Wu; Michael A Pagel; Leslie L Muldoon; Rongwei Fu; Edward A Neuwelt
Journal:  Anticancer Res       Date:  2017-08       Impact factor: 2.480

4.  Abituzumab Targeting of αV-Class Integrins Inhibits Prostate Cancer Progression.

Authors:  Yuan Jiang; Jinlu Dai; Zhi Yao; Greg Shelley; Evan T Keller
Journal:  Mol Cancer Res       Date:  2017-03-17       Impact factor: 5.852

5.  T-DM1-resistant cells gain high invasive activity via EGFR and integrin cooperated pathways.

Authors:  Yukinori Endo; Yi Shen; Lamis Abou Youssef; Nishant Mohan; Wen Jin Wu
Journal:  MAbs       Date:  2018-09-11       Impact factor: 5.857

6.  iTRAQ based quantitative proteomics approach validated the role of calcyclin binding protein (CacyBP) in promoting colorectal cancer metastasis.

Authors:  Dipanjana Ghosh; Zhihan Li; Xing Fei Tan; Teck Kwang Lim; Yubin Mao; Qingsong Lin
Journal:  Mol Cell Proteomics       Date:  2013-03-29       Impact factor: 5.911

7.  Targeting αV-integrins decreased metastasis and increased survival in a nude rat breast cancer brain metastasis model.

Authors:  Y Jeffrey Wu; Leslie L Muldoon; Seymur Gahramanov; Dale F Kraemer; Deborah J Marshall; Edward A Neuwelt
Journal:  J Neurooncol       Date:  2012-07-29       Impact factor: 4.130

Review 8.  Targeting bone physiology for the treatment of metastatic prostate cancer.

Authors:  Karen A Autio; Michael J Morris
Journal:  Clin Adv Hematol Oncol       Date:  2013-03

9.  Regulation of integrin αV subunit expression by sulfatide in hepatocellular carcinoma cells.

Authors:  Wei Wu; Yi Wei Dong; Peng Cheng Shi; Mei Yu; Da Fu; Chun Yi Zhang; Qian Qian Cai; Qian Lei Zhao; Ming Peng; Li Hui Wu; Xing Zhong Wu
Journal:  J Lipid Res       Date:  2013-01-22       Impact factor: 5.922

Review 10.  The role of TWIST1 in epithelial-mesenchymal transition and cancers.

Authors:  Qing-Qing Zhu; Chenhui Ma; Qian Wang; Yong Song; Tangfeng Lv
Journal:  Tumour Biol       Date:  2015-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.